Literature DB >> 1846062

Human immunodeficiency virus-induced immunosuppression: a risk factor for human papillomavirus infection.

R Matorras1, J M Ariceta, A Rementeria, J Corral, G Gutierrez de Terán, J Diez, F Montoya, F J Rodriguez-Escudero.   

Abstract

In a group of 92 women with genital condylomata, 15 (16.3%) human immunodeficiency virus-positive patients were found, whereas no case was detected in a control group of 100 women. The relative risk was greater than 19.28. Human immunodeficiency-positive status was associated with other parameters: lower age and parity, major frequency of induced abortions, and sexually transmitted diseases. Thus although human immunodeficiency-positive status seems to be a true risk factor in relation to the altered immunologic state, an indirect association cannot be discarded. Such patients should be screened closely for human papillomavirus infection and cervical cancer. Among human immunodeficiency-positive women, a more resistant behavior of human papillomavirus-associated lesions was detected (recurrence-persistence of 41.7% versus 12%), a fact that might also be in relation to the immunodepressed status.

Entities:  

Mesh:

Year:  1991        PMID: 1846062     DOI: 10.1016/0002-9378(91)90620-7

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  8 in total

1.  Imiquimod, a patient-applied immune-response modifier for treatment of external genital warts.

Authors:  K R Beutner; S K Tyring; K F Trofatter; J M Douglas; S Spruance; M L Owens; T L Fox; A J Hougham; K A Schmitt
Journal:  Antimicrob Agents Chemother       Date:  1998-04       Impact factor: 5.191

2.  Tissue specific HPV expression and downregulation of local immune responses in condylomas from HIV seropositive individuals.

Authors:  I Arany; T Evans; S K Tyring
Journal:  Sex Transm Infect       Date:  1998-10       Impact factor: 3.519

3.  Expression of CD40 and CD40L on peripheral blood mononuclear cells in patients with condyloma acuminatum.

Authors:  Dongxian Liu; Wen Jiang; Xingping Chen; Yingling Chen; Dongliang Yang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2006

4.  Comparison of PCR and hybrid capture methods for detection of human papillomavirus in injection drug-using women at high risk of human immunodeficiency virus infection.

Authors:  K V Shah; L Solomon; R Daniel; S Cohn; D Vlahov
Journal:  J Clin Microbiol       Date:  1997-02       Impact factor: 5.948

5.  Viral Venereal Diseases of the Skin.

Authors:  Theodora K Karagounis; Miriam K Pomeranz
Journal:  Am J Clin Dermatol       Date:  2021-05-18       Impact factor: 7.403

Review 6.  Role of human immunodeficiency virus infection in the pathogenesis of human papillomavirus-associated cervical neoplasia.

Authors:  L Braun
Journal:  Am J Pathol       Date:  1994-02       Impact factor: 4.307

7.  Impact of HIV on human papilloma virus-mediated cervical disease progression.

Authors:  Sten H Vermund; Karen F Kelley
Journal:  AIDS       Date:  2018-07-31       Impact factor: 4.177

8.  Novel family of gynecologic cancer antigens detected by anti-HIV antibody.

Authors:  E M Rakowicz-Szulczynska; D G McIntosh; P Morris; M Smith
Journal:  Infect Dis Obstet Gynecol       Date:  1994
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.